1. Home
  2. ONFO vs INM Comparison

ONFO vs INM Comparison

Compare ONFO & INM Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Onfolio Holdings Inc.

ONFO

Onfolio Holdings Inc.

HOLD

Current Price

$0.73

Market Cap

3.3M

Sector

Technology

ML Signal

HOLD

Logo InMed Pharmaceuticals Inc.

INM

InMed Pharmaceuticals Inc.

HOLD

Current Price

$1.11

Market Cap

3.6M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
ONFO
INM
Founded
2018
1981
Country
United States
Canada
Employees
N/A
N/A
Industry
Computer Software: Programming Data Processing
Biotechnology: Pharmaceutical Preparations
Sector
Technology
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
3.3M
3.6M
IPO Year
2022
N/A

Fundamental Metrics

Financial Performance
Metric
ONFO
INM
Price
$0.73
$1.11
Analyst Decision
Analyst Count
0
0
Target Price
N/A
N/A
AVG Volume (30 Days)
67.3K
105.8K
Earning Date
11-17-2025
02-11-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
$11,238,989.00
$4,798,116.00
Revenue This Year
N/A
N/A
Revenue Next Year
N/A
N/A
P/E Ratio
N/A
N/A
Revenue Growth
70.54
N/A
52 Week Low
$0.59
$1.03
52 Week High
$1.95
$8.27

Technical Indicators

Market Signals
Indicator
ONFO
INM
Relative Strength Index (RSI) 44.54 42.44
Support Level $0.70 $1.03
Resistance Level $0.85 $1.40
Average True Range (ATR) 0.07 0.09
MACD 0.01 0.01
Stochastic Oscillator 52.31 24.32

Price Performance

Historical Comparison
ONFO
INM

About ONFO Onfolio Holdings Inc.

Onfolio Holdings Inc actively manages small online businesses that operate in sectors with long-term growth opportunities, have positive and stable cash flows, face minimal threats of technological or competitive obsolescence, and can be managed by existing teams or have management teams largely in place. The company operates in two business segments: Business to Business (B2B) and Business to Consumers (B2C). The majority of its revenue is generated from the Business-to-Business (B2B) segment, which includes the results of operations of Eastern Standard, RevenueZen, DDS Rank, SEO Butler, Contentellect, DealPipe, and Onfolio LLC.

About INM InMed Pharmaceuticals Inc.

InMed Pharmaceuticals Inc is a Canada based clinical-stage biopharmaceutical company. The Company's operations consist of two operating and reportable segments, the InMed Pharma segment and the BayMedica Commercial segment. The InMed Pharma segment is largely organized around the research and development of small molecule pharmaceuticals drug candidates and the BayMedica Commercial segment is largely organized around manufacturing technologies to produce and commercialize bulk rare cannabinoids for sale as ingredients in the health and wellness industry. Its product portfolio includes INM-755, which is used for the treatment of epidermolysis bullosa; INM-088 for the treatment of glaucoma; INM-901 for Alzheimer's disease.

Share on Social Networks: